Kathleen Tymms

2.0k total citations
51 papers, 1.1k citations indexed

About

Kathleen Tymms is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Kathleen Tymms has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 15 papers in Hematology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Kathleen Tymms's work include Rheumatoid Arthritis Research and Therapies (28 papers), Autoimmune and Inflammatory Disorders Research (14 papers) and Systemic Lupus Erythematosus Research (13 papers). Kathleen Tymms is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (28 papers), Autoimmune and Inflammatory Disorders Research (14 papers) and Systemic Lupus Erythematosus Research (13 papers). Kathleen Tymms collaborates with scholars based in Australia, United States and United Kingdom. Kathleen Tymms's co-authors include J. Webb, Joon Kim, John M. Buckingham, Jane Zochling, Hedley Griffiths, Paul Bird, Lynden Roberts, Dave Nicholls, Peter Youssef and Susanna Proudman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Annals of the Rheumatic Diseases.

In The Last Decade

Kathleen Tymms

50 papers receiving 1.0k citations

Peers

Countries citing papers authored by Kathleen Tymms

Since Specialization

Citations

This map shows the geographic impact of Kathleen Tymms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Tymms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Tymms more than expected).

Fields of papers citing papers by Kathleen Tymms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Tymms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Tymms. The network helps show where Kathleen Tymms may publish in the future.

Co-authorship network of co-authors of Kathleen Tymms

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Tymms. A scholar is included among the top collaborators of Kathleen Tymms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Tymms. Kathleen Tymms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022 2024 ·Clinical Rheumatology ·Geoffrey Littlejohn, (unknown), Catherine O’Sullivan, Tegan Smith, Kathleen Tymms, Paul Bird, David Nicholls, Hedley Griffiths	1
2	A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience 2023 ·Frontiers in Digital Health ·Kathleen Tymms, Catherine O’Sullivan, Tegan Smith, Geoffrey Littlejohn, Tim Freeman, David Hoffman, (unknown), Hedley Griffiths, (unknown), Peter Youssef, David A. Mathers, Claire T. Deakin	3
3	Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset 2021 ·Clinical Rheumatology ·Kathleen Tymms, Belinda Butcher, Tracey L. Sletten, Tegan Smith, Catherine O’Sullivan, Geoffrey Littlejohn, (unknown), (unknown), Hedley Griffiths	6
4	Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study 2021 ·The Journal of Rheumatology ·Charlotte L. Bekker, (unknown), Mary A. De Vera, Susan J. Bartlett, Maarten de Wit, Lyn March, Beverley Shea, Vicki Evans, Dawn P. Richards, Allison Tong, Peter Tugwell, Kathleen Tymms, Marieke Voshaar, Ayano Kelly, Bart J. F. van den Bemt	2
5	Researchers’ perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence study 2021 ·BMC Rheumatology ·Shahrzad Salmasi, Ayano Kelly, Susan J. Bartlett, Maarten de Wit, Lyn March, Allison Tong, Peter Tugwell, Kathleen Tymms, Suzanne Verstappen, Mary A. De Vera, (unknown)	3
6	Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset 2019 ·The Journal of Rheumatology ·Peter Youssef, (unknown), Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms, Geoff Littlejohn	11
7	Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors 2018 ·Clinical Rheumatology ·Kathleen Tymms, Geoff Littlejohn, Hedley Griffiths, (unknown), Paul Bird, Fredrick Joshua, Peter Nash, M. Händel, Hamish McManus, Belinda Butcher, Peter Youssef	11
8	The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice 2017 ·International Journal of Rheumatology ·Lynden Roberts, Kathleen Tymms, (unknown), Geoffrey Littlejohn, Hedley Griffiths, Dave Nicholls, Paul Bird, Jennifer L. Young, Julie Hill, Jane Zochling	6
9	Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. 2017 ·PubMed ·Claire Owen, Gene‐Siew Ngian, (unknown), O. Moore, Wendy Stevens, Mandana Nikpour, Candice Rabusa, Susanna Proudman, Janet Roddy, Jane Zochling, Catherine Hill, Allan Sturgess, Kathleen Tymms, Peter Youssef, Joanne Sahhar	28
10	Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study 2017 ·International Journal of Rheumatic Diseases ·Paul Bird, Dave Nicholls, (unknown), (unknown), Hedley Griffiths, Lynden Roberts, Kathleen Tymms, Philip McCloud, Geoffrey Littlejohn	15
11	Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study 2015 ·The Journal of Rheumatology ·Geoffrey Littlejohn, Lynden Roberts, Paul Bird, (unknown), Hedley Griffiths, Dave Nicholls, Jennifer L. Young, Jane Zochling, Kathleen Tymms	12
12	The SMILE Study — Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis 2013 ·The Journal of Rheumatology ·Paul Bird, Hedley Griffiths, Kathleen Tymms, Dave Nicholls, Lynden Roberts, Mark Arnold, Simon Burnet, (unknown), James A. Scott, Jane Zochling, Geoff Littlejohn	38
13	LUNG DISEASE IS THE MAJOR CAUSE OF DEATH IN THE AUSTRALIAN SSc COHORT STUDY 2012 ·Lara D. Veeken ·Wendy Stevens, Vivek Thakkar, O. Moore, J. Byron, (unknown), Jane Zochling, Janet Roddy, J. Sahhar, Peter Nash, Peter Youssef, Gabor Major, Kathleen Tymms, Allan Sturgess, Mandana Nikpour	2
14	N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study 2012 ·Arthritis Research & Therapy ·Vivek Thakkar, Wendy Stevens, David L. Prior, O. Moore, J. Byron, Danny Liew, Karen A. Patterson, Pravin Hissaria, Janet Roddy, Jane Zochling, Joanne Sahhar, Peter Nash, Kathleen Tymms, David S. Celermajer, Eli Gabbay, Peter Youssef, Susanna Proudman, Mandana Nikpour	91
15	MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT 2011 ·Internal Medicine Journal ·(unknown), (unknown), J. Byron, Jane Zochling, Janet Roddy, J. Sahhar, Peter Nash, Peter Youssef, Kathleen Tymms, Allan Sturgess, Gabor Major, Catherine Hill, (unknown), Wallace Stevens	1
16	Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis 2008 ·Arthritis & Rheumatism ·Rachel Li, Craig Freeman, Di Yu, Elizabeth J. Hindmarsh, Kathleen Tymms, Christopher R. Parish, Paul N. Smith	76
17	Etanercept in severe active rheumatoid arthritis: first Australian experience 2006 ·Internal Medicine Journal ·(unknown), Kathleen Tymms, Benjamin James Wilson, Bruce Shadbolt, Andrew Brook, (unknown), (unknown)	6
18	What motivates senior clinicians to teach medical students? 2005 ·BMC Medical Education ·Jane E. Dahlstrom, (unknown), Darryl McGill, Cathy Owen, Kathleen Tymms, D. Watson	74
19	The Utility of Bone Scans in Rheumatology 1999 ·Clinical Nuclear Medicine ·Iain Duncan, (unknown), (unknown), Kathleen Tymms, Andrew Brook	3
20	Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis 1990 ·Clinical Rheumatology ·Kathleen Tymms, Elaine Beller, J. Webb, Leslie Schrieber, W. Watson Buchanan	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact